18Aug 2023
Aurobindo Pharma launches HIV triple combination product for children - Zee Business

Aurobindo Pharma launches HIV triple combination product for children - Zee Business

Aurobindo Pharma has introduced a triple HIV combination drug, the first generic option to receive tentative approval from the USFDA, in collaboration with ViiV Healthcare. The drug, a fixed-dose combination of Abacavir, Lamivudine, and Dolutegravir, will aid children aged 3 months or older and weighing 6-25 kg. The treatment aligns with WHO priorities and is awaiting approval from India's DCGI.

  • #family health

Like

Save

Share